Cash and Short Term Investments (Annual) Chart

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2018. Start Trial.
Date Value
December 31, 2025 44.34M
December 31, 2024 93.71M
December 31, 2023 118.30M
December 31, 2022 152.70M
Date Value
December 31, 2021 267.82M
December 31, 2020 156.45M
December 31, 2019 48.75M
December 31, 2018 62.51M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Anavex Life Sciences Corp. 102.58M
Vaxcyte, Inc. 1.561B
Foghorn Therapeutics, Inc. 160.14M
Caribou Biosciences, Inc. 139.34M
Arrowhead Pharmaceuticals, Inc. 919.37M